Mankind Pharma has received approval from the Competition Commission of India (CCI) for the acquisition of Bharat Serums and Vaccines (BSV) for $1.64 billion. The transaction involves acquiring a 100% stake in BSV. This strategic move is seen as a
Mankind Pharma, a prominent player in the Indian OTC drug market, has finalised the acquisition of Bharat Serums and Vaccines (BSV) from global investor Advent International. The deal, valued at Rs 13,630 crore, was announced in a joint statement on
Mankind Pharma is a company operating in the pharmaceutical industry. At Mankind Pharma, we aspire to aid the community in leading a healthy life by formulating, developing, commercializing, and delivering affordable and accessible medicines that satisfy urgent medical needs. Mankind
Stay ahead of trends and best practices
Exclusive downloads and podcasts
Get invites to special events and meetups 
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
